Isil MUTAF
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Paraoxonase enzyme and polymorphisms
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Chronic Kidney Disease and Diabetes 3
- Dialysis and Renal Disease Management 2
-
- Folate and B Vitamins Research 5
- Co-authors
- Oya Bayındır (24 shared papers)Sara Habif (19 shared papers)Osman Nuri Dılek (17 shared papers)Zuhal Parıldar (14 shared papers)Nevbahar Turgan (16 shared papers)Bilgin Özmen (5 shared papers)Ceyda Kabaroğlu (5 shared papers)Burcu Barutçuoğlu (4 shared papers)
In The Last Decade
Isil MUTAF
29 papers receiving 604 citations
Peers
Comparison fields: 5 of 86
- Clinical Biochemistry 80
- Nephrology 76
- Rheumatology 68
- Endocrinology, Diabetes and Metabolism 73
- Biochemistry 21
Countries citing papers authored by Isil MUTAF
This map shows the geographic impact of Isil MUTAF's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isil MUTAF with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isil MUTAF more than expected).
Fields of papers citing papers by Isil MUTAF
This network shows the impact of papers produced by Isil MUTAF. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isil MUTAF. The network helps show where Isil MUTAF may publish in the future.
Co-authors
The 25 scholars most cited alongside Isil MUTAF, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome. | 2011 | 58 |
| 2 | 2004 | 53 | |
| 3 | 2001 | 52 | |
| 4 | 2003 | 51 | |
| 5 | 2000 | 41 | |
| 6 | 2004 | 37 | |
| 7 | Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus. | 2002 | 34 |
| 8 | 1999 | 29 | |
| 9 | 2001 | 29 | |
| 10 | 2003 | 26 | |
| 11 | 2007 | 26 | |
| 12 | 2003 | 21 | |
| 13 | 2006 | 20 | |
| 14 | 2004 | 15 | |
| 15 | 1997 | 15 | |
| 16 | 2009 | 15 | |
| 17 | 1999 | 14 | |
| 18 | 2002 | 12 | |
| 19 | 2005 | 11 | |
| 20 | 2004 | 11 |
About Isil MUTAF
Isil MUTAF is a scholar working on Nephrology, Rheumatology, Nutrition and Dietetics, Clinical Biochemistry and Pediatrics, Perinatology and Child Health, having authored 29 papers that have together received 633 indexed citations. Recurring topics across this work include Folate and B Vitamins Research (5 papers), Chronic Kidney Disease and Diabetes (3 papers), Dialysis and Renal Disease Management (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Vitamin C and Antioxidants Research (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Esophageal and GI Pathology (2 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). The work is most often cited by research in Clinical Biochemistry (80 citations), Nephrology (76 citations), Rheumatology (68 citations), Endocrinology, Diabetes and Metabolism (73 citations) and Biochemistry (21 citations). Isil MUTAF has collaborated with scholars based in Türkiye and Czechia. Frequent co-authors include Oya Bayındır, Sara Habif, Osman Nuri Dılek, Zuhal Parıldar, Nevbahar Turgan, Bilgin Özmen, Ceyda Kabaroğlu, Burcu Barutçuoğlu, Saliha Aksun and Batuhan Özmen. Their work appears in journals such as Clinical Biochemistry, International Journal of Clinical & Laboratory Research, The Nephron journals/Nephron journals, Annals of Nutrition and Metabolism and Endocrine Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.